1887

Abstract

Studies of Epstein–Barr virus (EBV)-positive cell lines have identified several forms of virus latency, but the patterns of virus gene expression in EBV-positive tumour cells appear more variable. However, it is unclear to what extent these differences merely reflect the increased sensitivities of different detection methods. Here, the design and validation of novel real-time RT-PCR assays to quantify relative levels of EBV transcripts are described. When the new assays were used to screen a collection of endemic Burkitt's lymphoma tumours, abundant Qp-driven EBNA1 expression was found, whereas the other latent transcripts (with the exception of LMP2A) were either absent or detectable only at trace levels. Analysis of 12 nasopharyngeal carcinoma biopsies revealed significant levels of EBNA1 and LMP2A transcripts in almost every case but, in contrast to previous reports, LMP1 expression was undetectable. These new quantitative assays may help to provide a clearer picture of EBV gene expression in tumour material.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81906-0
2006-10-01
2019-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/10/2885.html?itemId=/content/journal/jgv/10.1099/vir.0.81906-0&mimeType=html&fmt=ahah

References

  1. Applied Biosystems ( 1997; ). Relative Quantitation of Gene Expression. ABI PRISM 7700 Sequence Detection System User Bulletin #2: Rev B. http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf
  2. Baer, R., Bankier, A. T., Biggin, M. D. & 9 other authors ( 1984; ). DNA sequence and expression of the B95-8 Epstein–Barr virus genome. Nature 310, 207–211.[CrossRef]
    [Google Scholar]
  3. Bodescot, M., Perricaudet, M. & Farrell, P. J. ( 1987; ). A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus. J Virol 61, 3424–3430.
    [Google Scholar]
  4. Brooks, L., Yao, Q. Y., Rickinson, A. B. & Young, L. S. ( 1992; ). Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66, 2689–2697.
    [Google Scholar]
  5. Busson, P., McCoy, R., Sadler, R., Gilligan, K., Tursz, T. & Raab-Traub, N. ( 1992; ). Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 66, 3257–3262.
    [Google Scholar]
  6. Busson, P., Edwards, R. H., Tursz, T. & Raab-Traub, N. ( 1995; ). Sequence polymorphism in the Epstein–Barr virus latent membrane protein (LMP)-2 gene. J Gen Virol 76, 139–145.[CrossRef]
    [Google Scholar]
  7. Cai, X., Schäfer, A., Lu, S., Bilello, J. P., Desrosiers, R. C., Edwards, R., Raab-Traub, N. & Cullen, B. R. ( 2006; ). Epstein – Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2, e23.[CrossRef]
    [Google Scholar]
  8. Chang, Y., Sheen, T. S., Lu, J., Huang, Y. T., Chen, J. Y., Yang, C. S. & Tsai, C. H. ( 1998; ). Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies. Lab Invest 78, 715–726.
    [Google Scholar]
  9. Chen, F., Hu, L.-F., Ernberg, I., Klein, G. & Winberg, G. ( 1995; ). Coupled transcription of Epstein–Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. J Gen Virol 76, 131–138.[CrossRef]
    [Google Scholar]
  10. Cochet, C., Martel-Renoir, D., Grunewald, V., Bosq, J., Cochet, G., Schwaab, G., Bernaudin, J.-F. & Joab, I. ( 1993; ). Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumour cells. Virology 197, 358–365.[CrossRef]
    [Google Scholar]
  11. Dambaugh, T., Hennessy, K., Chamnankit, L. & Kieff, E. ( 1984; ). U2 region of Epstein–Barr virus DNA may encode Epstein–Barr nuclear antigen 2. Proc Natl Acad Sci U S A 81, 7632–7636.[CrossRef]
    [Google Scholar]
  12. Edwards, R. H., Seillier-Moiseiwitsch, F. & Raab-Traub, N. ( 1999; ). Signature amino acid changes in latent membrane protein 1 distinguish Epstein–Barr virus strains. Virology 261, 79–95.[CrossRef]
    [Google Scholar]
  13. Fahraeus, R., Fu, H. L., Ernberg, I. & 9 other authors ( 1988; ). Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 42, 329–338.[CrossRef]
    [Google Scholar]
  14. Fennewald, S., van Santen, V. & Kieff, E. ( 1984; ). Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J Virol 51, 411–419.
    [Google Scholar]
  15. Gilligan, K. J., Rajadurai, J. & Lin, J.-C. ( 1991; ). Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol 65, 6252–6259.
    [Google Scholar]
  16. Gregory, C. D., Rowe, M. & Rickinson, A. B. ( 1990; ). Different Epstein–Barr virus–B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 71, 1481–1495.[CrossRef]
    [Google Scholar]
  17. Habeshaw, G., Yao, Q. Y., Bell, A. I., Morton, D. & Rickinson, A. B. ( 1999; ). Epstein-Barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas. J Virol 73, 965–975.
    [Google Scholar]
  18. Heussinger, N., Büttner, M., Ott, G., Brachtel, E., Pilch, B. Z., Kremmer, E. & Niedobitek, G. ( 2004; ). Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. J Pathol 203, 696–699.[CrossRef]
    [Google Scholar]
  19. Hitt, M. M., Allday, M. J., Hara, T., Karran, L., Jones, M. D., Busson, P., Tursz, T., Ernberg, I. & Griffin, B. E. ( 1989; ). EBV gene expression in an NPC-related tumour. EMBO J 8, 2639–2651.
    [Google Scholar]
  20. Hudson, G. S., Farrell, P. J. & Barrell, B. G. ( 1985; ). Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J Virol 53, 528–535.
    [Google Scholar]
  21. Kelly, G., Bell, A. & Rickinson, A. ( 2002; ). Epstein–Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nat Med 8, 1098–1104.[CrossRef]
    [Google Scholar]
  22. Laux, G., Economou, A. & Farrell, P. J. ( 1989; ). The terminal protein gene 2 of Epstein–Barr virus is transcribed from a bidirectional latent promoter region. J Gen Virol 70, 3079–3084.[CrossRef]
    [Google Scholar]
  23. Lossos, I. S., Czerwinski, D. K., Wechser, M. A. & Levy, R. ( 2003; ). Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies. Leukemia 17, 789–795.[CrossRef]
    [Google Scholar]
  24. Nicholls, J. M., Agathanggelou, A., Fung, K., Zeng, X. & Niedobitek, G. ( 1997; ). The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma. J Pathol 183, 164–168.[CrossRef]
    [Google Scholar]
  25. Niedobitek, G., Agathanggelou, A., Rowe, M., Jones, E. L., Jones, D. B., Turyaguma, P., Oryema, J., Wright, D. H. & Young, L. S. ( 1995; ). Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma. Blood 86, 659–665.
    [Google Scholar]
  26. Nonkwelo, C., Skinner, J., Bell, A., Rickinson, A. & Sample, J. ( 1996; ). Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J Virol 70, 623–627.
    [Google Scholar]
  27. Pfeffer, S., Zavolan, M., Grässer, F. A. & 8 other authors ( 2004; ). Identification of virus-encoded microRNAs. Science 304, 734–736.[CrossRef]
    [Google Scholar]
  28. Raab-Traub, N., Hood, R., Yang, C.-S., Henry, B., II & Pagano, J. S. ( 1983; ). Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 48, 580–590.
    [Google Scholar]
  29. Rickinson, A. B. & Kieff, E. ( 2001; ). Epstein-Barr virus. In Fields Virology, 4th edn, pp. 2575–2627. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott, Williams & Wilkins.
  30. Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H. & Rickinson, A. B. ( 1987; ). Differences in B cell growth phenotype reflect novel patterns of Epstein–Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 6, 2743–2751.
    [Google Scholar]
  31. Sample, J., Hummel, M., Braun, D., Birkenbach, M. & Kieff, E. ( 1986; ). Nucleotide sequences of mRNAs encoding Epstein–Barr virus nuclear proteins: a probable transcriptional initiation site. Proc Natl Acad Sci U S A 83, 5096–5100.[CrossRef]
    [Google Scholar]
  32. Schaefer, B. C., Strominger, J. L. & Speck, S. H. ( 1995; ). Redefining the Epstein–Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci U S A 92, 10565–10569.[CrossRef]
    [Google Scholar]
  33. Smith, P. R. & Griffin, B. E. ( 1992; ). Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J Virol 66, 706–714.
    [Google Scholar]
  34. Sung, N. S., Edwards, R. H., Seillier-Moiseiwitsch, F., Perkins, A. G., Zeng, Y. & Raab-Traub, N. ( 1998; ). Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China. Int J Cancer 76, 207–215.[CrossRef]
    [Google Scholar]
  35. Tao, Q., Robertson, K. D., Manns, A., Hildesheim, A. & Ambinder, R. F. ( 1998; ). Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91, 1373–1381.
    [Google Scholar]
  36. Tierney, R. J., Steven, N., Young, L. S. & Rickinson, A. B. ( 1994; ). Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68, 7374–7385.
    [Google Scholar]
  37. Woisetschlaeger, M., Strominger, J. L. & Speck, S. H. ( 1989; ). Mutually exclusive use of viral promoters in Epstein–Barr virus latently infected lymphocytes. Proc Natl Acad Sci U S A 86, 6498–6502.[CrossRef]
    [Google Scholar]
  38. Xue, S.-A., Labrecque, L. G., Lu, Q.-L. & 7 other authors ( 2002; ). Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi. Int J Cancer 99, 635–643.[CrossRef]
    [Google Scholar]
  39. Young, L. S., Dawson, C. W., Clark, D., Rupani, H., Busson, P., Tursz, T., Johnson, A. & Rickinson, A. B. ( 1988; ). Epstein–Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69, 1051–1065.[CrossRef]
    [Google Scholar]
  40. Young, L., Alfieri, C., Hennessy, K. & 7 other authors ( 1989; ). Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321, 1080–1085.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81906-0
Loading
/content/journal/jgv/10.1099/vir.0.81906-0
Loading

Data & Media loading...

Supplements

vol. , part 10, pp. 2885 – 2890

Supplementary Methods

Sequence alignment of LMP1 exons 2 and 3 obtained from 27 representative EBV isolates

Detection of EBV transcripts by real-time RT-PCR

Detection of EBV transcripts by conventional end-point RT-PCR assays

TaqMan primer/probe combinations used to detect EBV transcripts

[ Single PDF file] (464 KB)



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error